Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.
Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
Sustained expression of hepatocyte nuclear factor-6 leads to loss of pancreatic beta-cells by apoptosis.
Uncoupling salicylic acid-dependent cell death and defense-related responses from disease resistance in the Arabidopsis mutant acd5.
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? Breast Cancer Res Treat. 2013 Feb; 138(1):273-9.
View in:
PubMed
subject areas
Adult
Breast Neoplasms
Female
Genes, BRCA1
Heterozygote
Humans
Middle Aged
Mutation
Neoplasm Staging
Proportional Hazards Models
Young Adult
authors with profiles
Olufunmilayo Olopade